PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Centre for Clinical Epidemiology Lady Davis Institute for Medical Research, Jewish General Hospital, McGill University, Montreal, QC, Canada.\', \'Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Montreal, QC, Canada.\', \'Department of Human Genetics, McGill University, Montreal, QC, Canada.\', \'Kyoto-McGill International Collaborative School in Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.\', \'Japan Society for the Promotion of Science, Tokyo, Japan.\', \'Canada Excellence Research Chair in Genomic Medicine, McGill University, Montreal, QC, Canada.\', \'Medical Genetics, University of Siena, Siena, Italy.\', \'Genetica Medica Azienda Ospedaliera Universitaria Senese, Siena, Italy.\', \'Department of Twin Research, King\'s College London, London, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/ije/dyaa229
?:hasPublicationType
?:journal
  • International journal of epidemiology
is ?:pmid of
?:pmid
?:pmid
  • 33349849
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 3.969
?:rankingScore_hIndex
  • 174
is ?:relation_isRelatedTo_publication of
?:title
  • The effect of angiotensin-converting enzyme levels on COVID-19 susceptibility and severity: a Mendelian randomization study.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all